Device type · DXC
Clamp, Vascular
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DXC
Cardiovascular
Device class
Class II
FDA decisions since 2015
37
510(k), De Novo and PMA
Adverse event reports
868
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Clamp, Vascular
- Product code
- DXC
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.4450
- Specialty
- Cardiology
- FDA record
- Classification database entry for DXC
Latest FDA decisions
The 8 newest of 37 since 2015.
K260608 · Decided Nov 6, 2026 · 255 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
K262086 · Decided Jul 22, 2026 · 30 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
K260105 · Decided Jun 5, 2026 · 143 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
K252772 · Decided May 22, 2026 · 262 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
- Life Saving Tourniquet510(k)
K254060 · Decided Apr 3, 2026 · 107 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
K243627 · Decided Dec 31, 2025 · 401 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
K253070 · Decided Nov 20, 2025 · 58 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
Ningbo Dizegens Medical Science Co.,Ltd
K232577 · Decided Jan 18, 2024 · 146 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
Reports received
868
Received Nov 1, 2025 to Nov 19, 2026. Includes 4 of another or unstated type.
Malfunction reports
800
92% of reports
Injury reports
61
7.0% of reports
Death reports
3
0.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 26 | 8 | 0 | 0 |
| Jan 24 | 21 | 3 | 0 | 0 |
| Feb 24 | 16 | 5 | 0 | 0 |
| Mar 24 | 32 | 4 | 1 | 0 |
| Apr 24 | 21 | 7 | 0 | 0 |
| May 24 | 31 | 12 | 2 | 0 |
| Jun 24 | 34 | 6 | 0 | 0 |
| Jul 24 | 39 | 2 | 0 | 0 |
| Aug 24 | 14 | 3 | 0 | 0 |
| Sep 24 | 24 | 4 | 0 | 0 |
| Oct 24 | 29 | 3 | 0 | 0 |
| Nov 24 | 26 | 7 | 0 | 0 |
| Dec 24 | 29 | 0 | 0 | 0 |
| Jan 25 | 17 | 6 | 0 | 0 |
| Feb 25 | 27 | 10 | 0 | 0 |
| Mar 25 | 35 | 1 | 0 | 0 |
| Apr 25 | 20 | 8 | 0 | 1 |
| May 25 | 37 | 10 | 0 | 0 |
| Jun 25 | 44 | 2 | 0 | 0 |
| Jul 25 | 70 | 6 | 0 | 0 |
| Aug 25 | 23 | 5 | 0 | 0 |
| Sep 25 | 28 | 5 | 0 | 0 |
| Oct 25 | 20 | 6 | 1 | 0 |
| Nov 25 | 16 | 5 | 1 | 0 |
| Dec 25 | 43 | 2 | 0 | 0 |
| Jan 26 | 15 | 4 | 0 | 0 |
| Feb 26 | 11 | 7 | 0 | 0 |
| Mar 26 | 78 | 5 | 1 | 0 |
| Apr 26 | 115 | 5 | 0 | 0 |
| May 26 | 124 | 5 | 0 | 0 |
| Jun 26 | 104 | 7 | 1 | 0 |
| Jul 26 | 96 | 11 | 0 | 0 |
| Aug 26 | 88 | 6 | 0 | 1 |
| Sep 26 | 78 | 1 | 0 | 1 |
| Oct 26 | 32 | 3 | 0 | 2 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Terumo632
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Gas/Air Leak455
- Unintended Deflation376
- Fitting Problem75
- Deflation Problem45
- Detachment of Device or Device Component41
- Adverse Event Without Identified Device or Use Problem40
- Activation Problem23
- Contamination22
- Filling Problem15
- Mechanical Problem8
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions654
- Hematoma110
- Hemorrhage/Blood Loss/Bleeding57
- Insufficient Information40
- Swelling/ Edema20
- Bruise/Contusion10
- Pain6
- Fluid Discharge4
- Compartment syndrome3
- Diminished Pulse Pressure3
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2586-2025 · Started Aug 15, 2025 · Posted by FDA Sep 18, 2025
Reason given: Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.
Cause as FDA categorized it: Under Investigation by firm
Z-2587-2025 · Started Aug 15, 2025 · Posted by FDA Sep 18, 2025
Reason given: Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.
Cause as FDA categorized it: Under Investigation by firm
Z-2588-2025 · Started Aug 15, 2025 · Posted by FDA Sep 18, 2025
Reason given: Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.
Cause as FDA categorized it: Under Investigation by firm
Z-2637-2025 · Started Jul 1, 2025 · Posted by FDA Sep 26, 2025
Reason given: Device used for unilateral or bilateral occlusion of blood flow to the lower limbs has a potential manufacturing defect that may compromise the structural integrity of the device and device performance during use.
Cause as FDA categorized it: Nonconforming Material/Component
Z-1522-2024 · Started Feb 22, 2024 · Posted by FDA Apr 12, 2024
Reason given: The Surgical Tools and Cardiovascular Specialty marketing brochures distributed for Flo-Rester Disposable Internal Vessel Occluder, Flo-Thru Intraluminal Shunt, and Vascular Probe Intravascular Probe contain inaccurate content that does not align with the products Instructions for Use (IFU).
Cause as FDA categorized it: Under Investigation by firm
Z-1523-2024 · Started Feb 22, 2024 · Posted by FDA Apr 12, 2024
Reason given: The Surgical Tools and Cardiovascular Specialty marketing brochures distributed for Flo-Rester Disposable Internal Vessel Occluder, Flo-Thru Intraluminal Shunt, and Vascular Probe Intravascular Probe contain inaccurate content that does not align with the products Instructions for Use (IFU).
Cause as FDA categorized it: Under Investigation by firm
Z-1524-2024 · Started Feb 22, 2024 · Posted by FDA Apr 12, 2024
Reason given: The Surgical Tools and Cardiovascular Specialty marketing brochures distributed for Flo-Rester Disposable Internal Vessel Occluder, Flo-Thru Intraluminal Shunt, and Vascular Probe Intravascular Probe contain inaccurate content that does not align with the products Instructions for Use (IFU).
Cause as FDA categorized it: Under Investigation by firm
Z-0656-2024 · Started Dec 6, 2023 · Posted by FDA Jan 5, 2024
Reason given: Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).
Cause as FDA categorized it: Under Investigation by firm
Showing the 8 newest of 26 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.